European stocks drift as traders eye Ukraine talks, Jackson Hole
The pan-European STOXX 600 index (.STOXX), opens new tab was down about 0.2% after hitting its highest level since March on Friday, while the MSCI All Country World Index (.MIWD00000PUS), opens new tab hovered close to the record high touched last week.
Earlier in the Asian session, indices in Japan and Taiwan notched record peaks, while a gauge of Chinese stocks (.SSEC), opens new tab reached its highest level in a decade.
Investors were bracing for U.S. President Trump's meeting with Ukrainian President Zelenskiy and European leaders later on Monday to discuss the next steps to end the war in Ukraine, after Trump's summit with Russian President Vladimir Putin in Alaska on Friday.
While the summit did not result in an agreement, Trump afterwards appeared more aligned with Moscow on seeking a full peace deal with Ukraine instead of a ceasefire first.
"It will be a bit of a muted start to the week," said Lars Skovgaard, senior investment strategist at Danske Bank, after the Russia-U.S. talks on Friday.
Skovgaard added that whether or not a deal is reached, focus was already turning to the Kansas City Federal Reserve's August 21-23 Jackson Hole symposium, where Chair Jerome Powell is due to speak on the economic outlook and the central bank's policy framework.
Markets imply around an 85% chance of a quarter-point rate cut at the Fed's meeting on September 17, and are priced for a further cut by December.
"We see three rate cuts in the U.S. this year, and slower GDP growth but no recession," said Mark Matthews, head of research for Asia at Bank Julius Baer in Singapore. "The combination of those two should allow the rally to continue."
The prospect of lower borrowing costs globally has underpinned stock markets, and Japan's Nikkei (.N225), opens new tab climbed to a fresh record high. MSCI's broadest index of Asia-Pacific shares outside Japan (.MIAPJ0000PUS), opens new tab added 0.1%, having scaled a four-year peak last week.
In Europe, Germany's DAX (.GDAXI), opens new tab eased 0.3%. Britain's FTSE (.FTSE), opens new tab was down 0.1%.
S&P 500 and Nasdaq futures eased 0.1%, though both were near all-time highs.
Valuations have been underpinned by a solid earnings season as the S&P 500 EPS grew 11% on the year and 58% of companies raised their full-year guidance.
"Earnings results have continued to be exceptional for the mega-cap tech companies," said analysts at Goldman Sachs. "While Nvidia has yet to report, the Magnificent 7 apparently grew EPS by 26% year/year in 2Q, a 12% beat relative to consensus expectation coming into earnings season."
This week's results will provide some colour on the health of consumer spending with Home Depot, Target, Lowe's and Walmart all reporting.
In bond markets, the chance of Fed easing is keeping down short-term Treasury yields while the longer end is pressured by the risk of stagflation and giant budget deficits, leading to the steepest yield curve since 2021.
European bonds also have been pressured by the prospect of increased borrowing to fund higher defence spending, pushing German and French long-term yields to their highest since 2011.
Wagers on more Fed easing have weighed on the dollar, which dropped 0.4% against a basket of currencies last week to last stand at 97.858 .
The dollar was up 0.2% on the yen at 147.42 , while the euro slipped to $1.1682 after adding 0.5% last week.
In commodity markets, gold bounced 0.4% to $3,349 an ounce after losing 1.9% last week.
Oil prices edged higher as White House trade adviser Peter Navarro said India's purchases of Russian crude were funding Russia's war in Ukraine and had to stop, even as Trump backed away from threats to place more restrictions on Russian oil exports.
Brent was up 0.4% at $66.08 a barrel, while U.S. crude rose 0.5% t0 $63.11 per barrel.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
28 minutes ago
- Reuters
Trump administration in talks to take 10% stake in Intel, Bloomberg News reports
Aug 18 (Reuters) - The Trump administration is in talks to take a 10% stake in Intel by converting some or all of the struggling company's Chips Act grants into equity, Bloomberg News reported, citing a White House official and other people familiar with the matter. Shares of Intel (INTC.O), opens new tab fell about 3% on Monday, after rallying last week on hopes of U.S. federal support. A 10% stake in the American chipmaker would be worth about $10 billion. Intel has been slated to receive a combined $10.9 billion in Chips Act grants for commercial and military production, and the figure is roughly enough to pay for the government's holding, according to the Bloomberg report on Monday. Intel declined to comment on the report, while the White House did not respond to a request for comment. Reuters could not immediately verify the report. Media reports said last week that the U.S. government may buy a stake in Intel, after a meeting between CEO Lip-Bu Tan and President Donald Trump that was sparked by Trump's demand for the new Intel chief's resignation over his ties to Chinese firms. Federal backing could give Intel more breathing room to revive its loss-making foundry business, analysts have said, but it still suffers from a weak product roadmap and challenges in attracting customers to its new factories. "The fact that the U.S. government is stepping in to save a blue-chip American company likely means that Intel's competitive position was much worse than what anybody feared," said David Wagner, head of equity and portfolio manager at Intel shareholder Aptus Capital Advisors. Wagner added that while he was skeptical about the U.S. government investing taxpayer money into U.S. companies, it was better than having Intel become a state-owned entity. Aptus Capital Advisors holds 80,581 shares of Intel. Trump, who said the meeting with Tan was "very interesting" one, has taken an unprecedented approach to corporate interventions. He has pushed for multibillion-dollar government tie-ups in semiconductors and rare earths, such as a pay-for-play deal with Nvidia (NVDA.O), opens new tab and an arrangement with rare earth producer MP Materials (MP.N), opens new tab to secure critical minerals. The U.S. government has previously taken equity stakes in companies under stress. During the 2007-2009 financial crisis, it took a stake in General Motors (GM.N), opens new tab — later exiting the stake in 2013. Intel last year secured nearly $8 billion in subsidies, the largest outlay under the act, to build new factories in Ohio and other states as former CEO Pat Gelsinger bet on them to restore the company's manufacturing edge. Tan, however, pared back such ambitions, slowing construction in Ohio. He plans to build factories based on demand for the services, which analysts have said could put him at odds with Trump's push to shore up American manufacturing.
Reuters
an hour ago
- Reuters
Gold prices steady as investors assess Trump–Zelenskiy meeting
Aug 18 (Reuters) - Gold prices were largely steady on Monday, as investors focused on U.S. President Donald Trump's meeting with Ukrainian and European leaders, and the Federal Reserve's annual symposium in Jackson Hole this week. Spot gold was marginally down at $3,333.32 per ounce at 01:42 p.m. ET (1742 GMT), after hitting its lowest level since August 1 earlier in the session. U.S. gold futures for December delivery settled 0.1% lower at $3,378. The U.S. dollar gained 0.3%, making greenback-priced bullion more expensive for other currency holders. Trump said the U.S. would "help out" Europe in providing security for Ukraine as part of any deal to end Russia's war in Ukraine, as he and President Volodymyr Zelenskiy began a hastily arranged White House meeting to discuss a path to peace. The European leaders will meet with Trump afterwards in the White House's East Room at 3 p.m. EDT (1900 GMT), according to the White House. The meeting between Trump and Zelenskiy follows Trump's meeting with Putin on Friday, where the two leaders agreed to pursue a peace deal without implementing a ceasefire. "There was not much reaction in gold to the Putin-Trump meeting. I think we'll continue in this price range. The next inflection point is the Federal Reserve (conference)," said Marex analyst Edward Meir. Minutes from the U.S. central bank's July policy meeting are due on Wednesday, ahead of the Fed's annual conference in Jackson Hole, Wyoming, scheduled for August 21–23. Fed Chair Jerome Powell is expected to speak at the event. Investors will be watching out for Powell's remarks on the economic outlook. While markets have already priced in a 25 basis point cut, there's an outside chance of a 50 basis point reduction, which could drive gold prices higher, Meir said. Gold tends to perform strongly in environments with low interest rates and heightened uncertainty. Elsewhere, spot silver rose 0.1% at $38.02 per ounce, while platinum fell 0.1% to $1,334.10. Spot palladium gained 1% to $1,122.86 after falling to its lowest level since July 10 earlier in the session.
Reuters
an hour ago
- Reuters
CVS cannot obtain AIG, Chubb opioid coverage, top Delaware court rules
Aug 18 (Reuters) - CVS Health (CVS.N), opens new tab is not entitled to coverage from insurers, including AIG (AIG.N), opens new tab and Chubb , against thousands of lawsuits over its role in the nation's opioid crisis, Delaware's highest court ruled on Monday. The Delaware Supreme Court concluded that governments, hospitals, doctors and benefit plans that sued CVS sought damages for economic losses, not individualized "bodily injury" or "property damage" covered by CVS' general liability policies. It also rejected the argument that CVS' $5 billion nationwide settlement of opioid claims in November 2022 showed that the pharmacy chain and benefits manager had been sued for bodily injury. "The national settlement agreement funds expenses in response to the opioid crisis at-large, but it does not change the fact that the underlying lawsuits do not seek specific damages tied to individualized injuries," Chief Justice Collins Seitz wrote for a unanimous court. Neither CVS nor its lawyers immediately responded to requests for comment. AIG, Chubb and their lawyers did not immediately respond to similar requests. Many insurers have been sued by pharmacy chains, drugmakers and others seeking coverage for opioid-related bills. Chains had long argued they were merely filling doctors' prescriptions, but critics said the large quantities being dispensed and the potential for diversion were red flags. Walgreens (WBA.O), opens new tab and Walmart, opens new tab(WMT.N), opens new tab agreed to pay more than $8 billion in similar settlements. CVS, based in Woonsocket, Rhode Island, had been appealing two Delaware Superior Court decisions denying insurance coverage in more than 2,300 lawsuits, according to Monday's decision. Governments complained about increased spending to treat opioid addiction, hospitals reported strains on their health systems, and third-party payors such as employee benefit funds cited costs of prescription purchases and addiction treatment. The Delaware Supreme Court ruled in Chubb's favor in a similar case involving Rite Aid in 2022. CVS claimed that its own policies offered broader coverage, but the court found the policies "similar in all material respects" to Rite Aid's. The case is In re CVS Opioid Insurance Litigation, Delaware Supreme Court, No. 482.
